MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial

Clinical trial NCT07505303 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07505303
Sponsor: Eccogene
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Obesity Weight Management

Start date: 2026-03-23
Primary completion: 2026-10-15
Enrollment: 151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.